Market cap
$576 Mln
Revenue (TTM)
$447 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
33.74
-
EV/EBITDA
-11.8
-
Debt to Equity
0.7
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
81,993,104
7 Years Aggregate
CFO
$-233.54 Mln
EBITDA
$-184.07 Mln
Net Profit
$-902.38 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Accolade Inc (ACCD)
| 105.3 | 0.7 | 109.6 | -23.6 | -24.1 | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Accolade Inc (ACCD)
| -71.2 | 54.2 | -70.4 | -39.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Accolade Inc (ACCD)
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the... United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington. Read more
-
Chairman of the Board & CEO
Mr. Rajeev Singh
-
Chairman of the Board & CEO
Mr. Rajeev Singh
-
Headquarters
Seattle, WA
-
Website
FAQs for Accolade Inc (ACCD)
What is the current share price of Accolade Inc (ACCD) Today?
The share price of Accolade Inc (ACCD) is $7.02 (NASDAQ) as of 08-Apr-2025 09:30 EDT. Accolade Inc (ACCD) has given a return of -24.08% in the last 3 years.
What is the current PB & PE ratio of Accolade Inc (ACCD)?
Since, TTM earnings of Accolade Inc (ACCD) is negative, P/E ratio is not available.
The P/B ratio of Accolade Inc (ACCD) is 1.84 times as on 08-Apr-2025, a 48 discount to its peers’ median range of 3.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
What is the 52 Week High and Low of Accolade Inc (ACCD)?
The 52-week high and low of Accolade Inc (ACCD) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Accolade Inc (ACCD)?
Accolade Inc (ACCD) has a market capitalisation of $ 576 Mln as on 08-Apr-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Accolade Inc (ACCD)?
Before investing in Accolade Inc (ACCD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.